Objective: To investigate the relative bioavailability and bioequivalence, in fasting and fed conditions, of repeated doses of two omeprazole enteric-coated formulations in healthy volunteers.

Rising healthcare costs are an alarming concern to the U.S. economy. Our national health expenditure grew from $4.1 trillion ...

Table III. Pharmacokinetic parameters for rebamipide following oral administration of granules or a tablet at a dose of 100mg in 27 healthy adult male volunteers [mean (SD)] ...

Daily oral edaravone (Radicava ORS) was not superior to the FDA-approved on/off regimen in amyotrophic lateral sclerosis (ALS ...

Steep costs have driven some Aussies to switch from brand-name medicine to its generic counterpart. Here's the price ...

AI-based clinical simulation systems can be a game-changer for the pharmaceutical industry. The ability to predict clinical ...

During a recent webinar, experts discussed critical regulatory aspects for generics and biosimilars, highlighting strategies ...

These studies are critical for assessing the bioavailability and bioequivalence of drugs, particularly nasal aerosols and sprays. The FDA's guidance on bioavailability and bioequivalence emphasizes ...

Given recent approvals and a promising pipeline, new biomedical HIV prevention tools for women have the potential to ...

Gireesh Babu, New Delhi Monday, October 21, 2024, 08:00 Hrs [IST] ...

VANCOUVER, BC / ACCESSWIRE / October 7, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC ...

Rani Therapeutics Holdings (RANI – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...